Medicare Enrolled
Dr. Sriram Dasari, MD
Urology Physician · Chula Vista, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dasari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dasari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dasari
Dr. Sriram Dasari is an urology physician in Chula Vista, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dasari performed 5,088 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dasari received a total of $3,604 from 31 pharmaceutical and/or device companies across 116 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dasari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 19% volume in CA
$3,604 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,088
Medicare services
Top 19% in CA for urology physician
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,800 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
436 | $80 | $250 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
379 | $2 | $7 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
261 | $3 | $11 |
| PSA test (prostate cancer screening) | 260 | $18 | $72 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
219 | $53 | $170 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
122 | $8 | $10 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
83 | $20 | $63 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $132 | $550 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
45 | $83 | $526 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
43 | $7 | $40 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
36 | $18 | $75 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
35 | $24 | $70 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
28 | $91 | $475 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
28 | $8 | $44 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
28 | $60 | $251 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
26 | $5 | $14 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
26 | $25 | $73 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $110 | $383 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
25 | $183 | $628 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
22 | $8 | $20 |
| Antimicrobial drug evaluation Assessment of the patient's response to antibiotic, antifungal, or antiviral therapy. |
22 | $7 | $20 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
14 | $71 | $250 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
13 | $20 | $80 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
11 | $188 | $484 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
11 | $10 | $239 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
11 | $110 | $252 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$3,604
Total received (2018-2024)
Avg $515/year across 7 years
Top 42% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
116
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$201
2023
$446
2022
$623
2021
$1,080
2020
$477
2019
$429
2018
$348
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$81
Sumitomo Pharma America, Inc.
$50
ABBVIE INC.
$32
UROGEN PHARMA, INC.
$19
PFIZER INC.
$19
Top 3 companies account for 81.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$758
BOSTON SCIENTIFIC CORPORATION
$375
PROCEPT BioRobotics Corporation
$312
AstraZeneca Pharmaceuticals LP
$252
PFIZER INC.
$251
Hollister Incorporated
$216
Ferring Pharmaceuticals Inc.
$192
Medtronic, Inc.
$169
Medtronic USA, Inc.
$158
SRS Medical Systems, Inc.
$135
NeoTract Inc.
$112
Amgen Inc.
$88
UROVANT SCIENCES INC
$68
UroGen Pharma, Inc.
$62
Dendreon Pharmaceuticals LLC
$56
Sumitomo Pharma America, Inc.
$50
Blue Earth Diagnostics Limited
$44
Myovant Sciences Inc.
$38
ABBVIE INC.
$32
UROGEN PHARMA, INC.
$31
Ambu Inc.
$30
Janssen Biotech, Inc.
$28
Avadel Specialty Pharmaceuticals, LLC
$24
AbbVie Inc.
$20
Clovis Oncology, Inc.
$19
Rochester Medical Corporation
$18
ROCHESTER MEDICAL CORPORATION
$16
Endo Pharmaceuticals Inc.
$15
Axonics Modulation Technologies, Inc.
$13
Merck Sharp & Dohme Corporation
$12
Myriad Genetic Laboratories, Inc.
$12
Top 3 companies account for 40.1% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · Axonics r-SNM System · Axumin · BOTOX · ERLEADA · Erleada · FIRMAGON · GEMTESA · GREENLIGHT · INTERSTIM · JELMYTO · LYNPARZA · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · ORGOVYX · PROVENGE · Prolaris · Prolia · REZUM · Rubraca · UroCuff · UroLift · VESICARE · VaPro Plus Pocket · XGEVA · XIAFLEX · XTANDI · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
118
County median income
$102,285
Nearest hospital to ZIP centroid (approximate)
SHARP CHULA VISTA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dasari is a mixed practice specialist, with above-average Medicare volume (top 19% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dasari experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Dasari performed 2,800 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dasari receive payments from pharmaceutical companies?
Yes. Dr. Dasari received a total of $3,604 from 31 companies across 116 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dasari's costs compare to other urology physicians in Chula Vista?
Dr. Dasari's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dasari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Chula Vista
Browse urology physicians in Chula Vista ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology